Seres Therapeutics (1S90.STU) Q3 2026 Earnings

5AugConfirmed
Q2 2026
Next
-1.98
-1.86
-1.73
-1.6

Details

Expected EPS
-1.9821169999999997
Actual EPS
N/A
Surprise EPS
1.98
Surprise Percent
+100%

Description

Seres Therapeutics (1S90.STU) will report earnings of for Q3 2026 on August 05, 2026.

0 Comments

Share your thoughts